Madrigal Pharmaceuticals, Inc.MDGLNASDAQ
Loading
Year-over-year net income growth rate
Latest
48.70%
↑ 408% vs avg
Percentile
P97
Near historical high
Streak
1 qtr
Consecutive growthAccelerating
Average
-15.83%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 48.70% |
| Q3 2025 | -170.07% |
| Q2 2025 | 42.27% |
| Q1 2025 | -23.26% |
| Q4 2024 | 44.45% |
| Q3 2024 | 29.62% |
| Q2 2024 | -3.00% |
| Q1 2024 | -31.51% |
| Q4 2023 | -13.63% |
| Q3 2023 | -15.08% |
| Q2 2023 | -11.58% |
| Q1 2023 | 10.49% |
| Q4 2022 | -5.80% |
| Q3 2022 | -14.80% |
| Q2 2022 | -22.97% |
| Q1 2022 | 10.89% |
| Q4 2021 | -2.30% |
| Q3 2021 | -2.35% |
| Q2 2021 | -17.33% |
| Q1 2021 | 11.12% |
| Q4 2020 | -2.00% |
| Q3 2020 | -18.24% |
| Q2 2020 | -35.67% |
| Q1 2020 | -30.26% |
| Q4 2019 | -29.45% |
| Q3 2019 | -8.78% |
| Q2 2019 | -30.63% |
| Q1 2019 | -31.42% |
| Q4 2018 | -34.81% |
| Q3 2018 | -31.76% |
| Q2 2018 | -1.51% |
| Q1 2018 | 24.64% |
| Q4 2017 | -0.98% |
| Q3 2017 | -0.19% |
| Q2 2017 | -39.14% |
| Q1 2017 | 22.59% |
| Q4 2016 | 44.84% |
| Q3 2016 | -388.31% |
| Q2 2016 | 55.90% |
| Q1 2016 | 38.08% |